Cargando…
Structural and Functional Characterization of the Secondary Mutation N126K Selected by Various HIV-1 Fusion Inhibitors
Peptides derived from the C-terminal heptad repeat (CHR) region of HIV-1 gp41 is potent viral membrane fusion inhibitors, such as the first clinically approved peptide drug T20 and a group of newly-designed peptides. The resistance profiles of various HIV-1 fusion inhibitors were previously characte...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7150849/ https://www.ncbi.nlm.nih.gov/pubmed/32197300 http://dx.doi.org/10.3390/v12030326 |
_version_ | 1783521112991203328 |
---|---|
author | Yu, Danwei Su, Yang Ding, Xiaohui Zhu, Yuanmei Qin, Bo Chong, Huihui Cui, Sheng He, Yuxian |
author_facet | Yu, Danwei Su, Yang Ding, Xiaohui Zhu, Yuanmei Qin, Bo Chong, Huihui Cui, Sheng He, Yuxian |
author_sort | Yu, Danwei |
collection | PubMed |
description | Peptides derived from the C-terminal heptad repeat (CHR) region of HIV-1 gp41 is potent viral membrane fusion inhibitors, such as the first clinically approved peptide drug T20 and a group of newly-designed peptides. The resistance profiles of various HIV-1 fusion inhibitors were previously characterized, and the secondary mutation N126K in the gp41 CHR was routinely identified during the in vitro and in vivo selections. In this study, the functional and structural relevance of the N126K mutation has been characterized from multiple angles. First, we show that a single N126K mutation across several HIV-1 isolates conferred mild to moderate cross-resistances. Second, the N126K mutation exerted different effects on Env-mediated HIV-1 entry and cell-cell fusion. Third, the N126K mutation did not interfere with the expression and processing of viral Env glycoproteins, but it disrupted the Asn126-based glycosylation site in gp41. Fourth, the N126K mutation was verified to enhance the thermal stability of 6-HB conformation. Fifth, we determined the crystal structure of a 6-HB bearing the N126K mutation, which revealed the interhelical and intrahelical interactions underlying the increased thermostability. Therefore, our data provide new information to understand the mechanism of HIV-1 gp41-mediated cell fusion and its resistance mode to viral fusion inhibitors. |
format | Online Article Text |
id | pubmed-7150849 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-71508492020-04-20 Structural and Functional Characterization of the Secondary Mutation N126K Selected by Various HIV-1 Fusion Inhibitors Yu, Danwei Su, Yang Ding, Xiaohui Zhu, Yuanmei Qin, Bo Chong, Huihui Cui, Sheng He, Yuxian Viruses Article Peptides derived from the C-terminal heptad repeat (CHR) region of HIV-1 gp41 is potent viral membrane fusion inhibitors, such as the first clinically approved peptide drug T20 and a group of newly-designed peptides. The resistance profiles of various HIV-1 fusion inhibitors were previously characterized, and the secondary mutation N126K in the gp41 CHR was routinely identified during the in vitro and in vivo selections. In this study, the functional and structural relevance of the N126K mutation has been characterized from multiple angles. First, we show that a single N126K mutation across several HIV-1 isolates conferred mild to moderate cross-resistances. Second, the N126K mutation exerted different effects on Env-mediated HIV-1 entry and cell-cell fusion. Third, the N126K mutation did not interfere with the expression and processing of viral Env glycoproteins, but it disrupted the Asn126-based glycosylation site in gp41. Fourth, the N126K mutation was verified to enhance the thermal stability of 6-HB conformation. Fifth, we determined the crystal structure of a 6-HB bearing the N126K mutation, which revealed the interhelical and intrahelical interactions underlying the increased thermostability. Therefore, our data provide new information to understand the mechanism of HIV-1 gp41-mediated cell fusion and its resistance mode to viral fusion inhibitors. MDPI 2020-03-18 /pmc/articles/PMC7150849/ /pubmed/32197300 http://dx.doi.org/10.3390/v12030326 Text en © 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Yu, Danwei Su, Yang Ding, Xiaohui Zhu, Yuanmei Qin, Bo Chong, Huihui Cui, Sheng He, Yuxian Structural and Functional Characterization of the Secondary Mutation N126K Selected by Various HIV-1 Fusion Inhibitors |
title | Structural and Functional Characterization of the Secondary Mutation N126K Selected by Various HIV-1 Fusion Inhibitors |
title_full | Structural and Functional Characterization of the Secondary Mutation N126K Selected by Various HIV-1 Fusion Inhibitors |
title_fullStr | Structural and Functional Characterization of the Secondary Mutation N126K Selected by Various HIV-1 Fusion Inhibitors |
title_full_unstemmed | Structural and Functional Characterization of the Secondary Mutation N126K Selected by Various HIV-1 Fusion Inhibitors |
title_short | Structural and Functional Characterization of the Secondary Mutation N126K Selected by Various HIV-1 Fusion Inhibitors |
title_sort | structural and functional characterization of the secondary mutation n126k selected by various hiv-1 fusion inhibitors |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7150849/ https://www.ncbi.nlm.nih.gov/pubmed/32197300 http://dx.doi.org/10.3390/v12030326 |
work_keys_str_mv | AT yudanwei structuralandfunctionalcharacterizationofthesecondarymutationn126kselectedbyvarioushiv1fusioninhibitors AT suyang structuralandfunctionalcharacterizationofthesecondarymutationn126kselectedbyvarioushiv1fusioninhibitors AT dingxiaohui structuralandfunctionalcharacterizationofthesecondarymutationn126kselectedbyvarioushiv1fusioninhibitors AT zhuyuanmei structuralandfunctionalcharacterizationofthesecondarymutationn126kselectedbyvarioushiv1fusioninhibitors AT qinbo structuralandfunctionalcharacterizationofthesecondarymutationn126kselectedbyvarioushiv1fusioninhibitors AT chonghuihui structuralandfunctionalcharacterizationofthesecondarymutationn126kselectedbyvarioushiv1fusioninhibitors AT cuisheng structuralandfunctionalcharacterizationofthesecondarymutationn126kselectedbyvarioushiv1fusioninhibitors AT heyuxian structuralandfunctionalcharacterizationofthesecondarymutationn126kselectedbyvarioushiv1fusioninhibitors |